Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470.

× No keyword cloud information.

29 in total

1. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates.

Authors: L E Dike; C S Chen; M Mrksich; J Tien; G M Whitesides; D E Ingber
Journal: In Vitro Cell Dev Biol Anim Date: 1999-09 Impact factor: 2.416

Review 2. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.

Authors: A J Hayes; L Y Li; M E Lippman
Journal: BMJ Date: 1999-03-27

Review 3. Targeting angiogenesis in advanced cervical cancer.

Authors: Ramez N Eskander; Krishnansu S Tewari
Journal: Ther Adv Med Oncol Date: 2014-11 Impact factor: 8.168

4. Inhibitory effects of TNP-470 in combination with BCNU on tumor growth of human glioblastoma xenografts.

Authors: Dongxiao Yao; Hongyang Zhao; Fangcheng Zhang; Jian Chen; Xiaobing Jiang; Xianli Zhu
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2010-12-22

5. Endothelial cell culture: beginnings of modern vascular biology.

Authors: Ralph L Nachman; Eric A Jaffe
Journal: J Clin Invest Date: 2004-10 Impact factor: 14.808

6. Anti-vascular therapy: a new approach to cancer treatment.

Authors: A J Hayes; L Y Li; M E Lippman
Journal: West J Med Date: 2000-01

Review 7. Evidence-Based Treatment Paradigms for Management of Invasive Cervical Carcinoma.

Authors: Krishnansu S Tewari; Bradley J Monk
Journal: J Clin Oncol Date: 2019-08-12 Impact factor: 44.544

8. Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.

Authors: Alison K Esser; Anne H Schmieder; Michael H Ross; Jingyu Xiang; Xinming Su; Grace Cui; Huiying Zhang; Xiaoxia Yang; John S Allen; Todd Williams; Samuel A Wickline; Dipanjan Pan; Gregory M Lanza; Katherine N Weilbaecher
Journal: Nanomedicine Date: 2015-10-27 Impact factor: 5.307

Review 9. Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicology.

Authors: Ramez N Eskander; Krishnansu S Tewari
Journal: Future Oncol Date: 2015 Impact factor: 3.404

10. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.

Authors: Patrick M Winter; Shelton D Caruthers; Huiying Zhang; Todd A Williams; Samuel A Wickline; Gregory M Lanza
Journal: JACC Cardiovasc Imaging Date: 2008-09